Catherine R. Kostlan

Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally active, nonulcerogenic antiinflammatory agents

Michael D. Mullican, Michael W. Wilson, David T. Conner et al. · Journal of Medicinal Chemistry · 1993 · 372 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity

Paul C. Unangst, David T. Connor, Wiaczeslaw A. Cetenko et al. · Journal of Medicinal Chemistry · 1994 · 163 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Styrylpyrazoles, styrylisoxazoles, and styrylisothiazoles. Novel 5-lipoxygenase and cyclooxygenase inhibitors

Thomas R. Belliotti, Amal M. Boctor, D. T. CONNOR et al. · Journal of Medicinal Chemistry · 1991 · 91 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

The design and synthesis of sulfonamides as caspase-1 inhibitors

William G. Harter, Hans Albrect, Kenneth D. Brady et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 57 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +9

Nonsteroidal anti-inflammatory drug hydroxamic acids. Dual inhibitors of both cyclooxygenase and 5-lipoxygenase

Daniel L. Flynn, Thomas Capiris, W. J. Cetenko et al. · Journal of Medicinal Chemistry · 1990 · 46 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9